Paul Hastings (Washington)

Noah Pinegar

Paul Hastings (Washington)
Associate

Noah Pinegar in an associate in the Antitrust and Competition practice of Paul Hastings and is based in the firm’s Washington, D.C. office. Mr. Pinegar represents clients in merger reviews before the Federal Trade Commission, the U.S. Department of Justice, and international enforcers, as well as in civil and criminal investigations and litigation. During his time as an attorney with the Federal Trade Commission, Mergers I division, Mr. Pinegar was a member of multiple litigation/trial teams, including FTC v. Staples/Office Depot, and high-profile investigations in industries such as pharmaceuticals, medical devices, pharmacies, and pharmacy benefit management.

Auteurs associés

Paul Hastings (Paris)
Paul Hastings (San Francisco)
Paul Hastings (San Francisco)
Paul Hastings (Washington)
Paul Hastings (Paris)

Articles

147 Bulletin

Michael Cohen, Noah Pinegar The US District Court for the Eastern District of New York holds that Chinese law did not compel the defendants in a cartel case to reach agreements on price and output (In re Vitamin C Antitrust Litigation)

147

In a recent, strongly worded federal antitrust decision, pleas for international comity by China’s nationalized vitamin industry and its regulatory overseer, China’s foremost trade industry, fell short in a showdown with U.S. domestic antitrust laws. The case indicates that foreign compulsion (...)

9239 Revue

Alden F. Abbott, Robin Adelstein, Megan Browdie, Michael A. Carrier, Peter C. Carstensen, Samuel Clark, Lisl J. Dunlop, Harry First, Albert A. Foer, Eleanor M. Fox, Jacqueline Grise, Ryan Kantor, Donald C. Klawiter, John Kwoka, James Langenfeld, Tad Lipsky, Alessandro Massolo, Howard Morse, Gabriella Muscolo, James Bo Pearl, Noah Pinegar, Chris Ring, Christopher Sagers, Richard S. Taffet, Willard K. Tom, Eliot Turner, Doug Tween, Tommaso Valletti, Michael L. Weiner The new US antitrust administration

9239

Ce dossier Concurrences se concentre sur l’antitrust et ses possibles développements à la suite des élections présidentielles américaines. Il s’interroge sur les changements et défis attendus pour 2021 sous la nouvelle administration Biden, et leurs impacts sur la législation et la politique de la (...)

Envoyer un message